← Leaderboards
Judd F Hultquist
Northwestern University At Chicago
$4,133,972
Attributed
$5,144,451
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,144,451 · 6
By mechanism
R01$3,570,145 · 2
R21$1,305,506 · 3
K22$268,800 · 1
Top collaborators
- Bria M Coates2 shared
- Ali Shilatifard2 shared
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsReportingVirusInfectionDesignViralMutationComplexCell LineHiv InfectionsLinkGenesT-LymphocyteHiv-1MutantResponseSiteBindingPhenotypeImmune ResponseIntegration Host FactorsIntegration SiteKnock-OutCrispr/Cas Technology
Grant awards (15)
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-Infection$789,976
R01 · FY2025 · AI · contact PI
Deciphering the Role of CPSF6 in HIV Infection$395,200
R01 · FY2025 · AI · contact PI
A Functional Genomics Platform for the de novo Identification of Disease-relevant Alleles$200,000
R21 · FY2025 · TR · contact PI
Viral and Host Dynamics during Pediatric COVID-19 and Respiratory Virus Co-Infection$804,976
R01 · FY2024 · AI · contact PI
Deciphering the Role of CPSF6 in HIV Infection$395,200
R01 · FY2024 · AI · contact PI
A Functional Genomics Platform for the de novo Identification of Disease-relevant Alleles$240,000
R21 · FY2024 · TR · contact PI
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents$193,003
R21 · FY2024 · AI · contact PI
Deciphering the Role of CPSF6 in HIV Infection$395,200
R01 · FY2023 · AI · contact PI
Exploring Small Molecule Inhibitors of PAF1C as Novel HIV Latency Reversal Agents$233,003
R21 · FY2023 · AI · contact PI
Deciphering the Role of CPSF6 in HIV Infection$395,200
R01 · FY2022 · AI · contact PI
Assessing the Risk of SARS-CoV-2 Remdesivir Resistance$200,000
R21 · FY2022 · AI · contact PI
Deciphering the Role of CPSF6 in HIV Infection$394,393
R01 · FY2021 · AI · contact PI
Assessing the Risk of SARS-CoV-2 Remdesivir Resistance$239,500
R21 · FY2021 · AI · contact PI
The Influence of Early Integration Events on HIV Latency and Reactivation Potential$108,000
K22 · FY2019 · AI · contact PI
The Influence of Early Integration Events on HIV Latency and Reactivation Potential$160,800
K22 · FY2018 · AI · contact PI